Improve Patient Psychological Safety in Medication Talks

Patients’ willingness to raise medication concerns depends on patient psychological safety, according to the PLOS One study (El-Kotob et al., 2026) which explored medication conversations and psychological safety in primary and community care.

• The PLOS One study published on August 20, 2026 included 21 participants interviewed between May and August 2024, and found that respectful communication, clear information, and invitation to participate supported psychological safety.
• In the PLOS One dataset, 19 participants were aged 40 or older and 14 participants identified as White, supporting the study’s note on limited demographic diversity (El-Kotob et al., 2026).
• Participant quotes in the PLOS One study revealed common barriers: shame, dismissal, and uncertainty reduced willingness to speak up; for example participant P10 said, "I try to treat providers respectfully and behave in an intelligent way with them too. And they treat me as an equal."
• The PLOS One authors recommend multi-level changes (clinician communication, appointment length, training) to foster psychologically safe medication conversations (El-Kotob et al., 2026).

The PLOS One study analyzed patient narratives to explore how psychological safety shapes medication conversations during primary and community care encounters.

According to the PLOS One study (El-Kotob et al., 2026), researchers conducted semi-structured interviews and focus groups with adults who had taken at least one prescribed medication for three months or longer, with data collection occurring between 01/05/2024 and 31/08/2024.

According to the PLOS One study (El-Kotob et al., 2026), the analysis used the Patient Psychological Safety (PPS) framework with three deductive constructs: Patient Belonging, Patient Learning, and Patient Participating.

According to the PLOS One study (El-Kotob et al., 2026), the final sample included 21 participants and the authors reported that psychological safety emerged as central to whether patients asked questions, shared concerns, and joined decision-making.

Qualitative researchers should treat patient psychological safety as a measurable analytic focus rather than a background theme.

According to the PLOS One study (El-Kotob et al., 2026), coding around the PPS constructs (Belonging, Learning, Participating) clarifies how communication patterns shape willingness to disclose medication problems.

Researchers should prioritize purposive sampling to capture diversity: the PLOS One authors warn that their sample (n = 21, largely older and White) limits transferability and recommend targeted recruitment for underrepresented groups.

When designing studies, researchers should document data collection dates and settings exactly as the PLOS One study did (e.g., May–August 2024), because temporal context and care-mode (virtual vs in-person) affect psychological safety.

The PLOS One study (El-Kotob et al., 2026) shows that psychological safety is central to whether patients disclose medication concerns and participate in decisions, and that respectful communication, clear information, and invitation to participate support safer medication use.

Qualitative researchers can adopt the PPS framework, purposive sampling for diversity, and AI-assisted analysis to produce timely, reproducible evidence for clinicians and policymakers.

If you want to prototype a PPS codebook, run cross-segment analyses, or generate shareable evidence tables from interview transcripts, try an AI-enabled platform built for qualitative research.

Get started: Try Evidano for free.